X. Pham

Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine

Bin Zhou, V. Shinde, N. Patel, 2020, medRxiv.

Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial.

Bin Zhou, Nan Wang, V. Shinde, 2021, The Lancet. Infectious diseases.

Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy.

L. Abel, A. Alcaïs, E. Schurr, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of the Safety and Immunogenicity of a Novel Matrix-M-adjuvanted Nanoparticle Influenza Vaccine with a Quadrivalent Seasonal Influenza Vaccine in Older Adults: A Randomized Controlled Trial

V. Shinde, N. Patel, G. Glenn, 2020, medRxiv.